Philip H. Elsinga
PET-center
University Hospital Groningen
Netherlands
Name/email consistency: high
- Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain. Elsinga, P.H., Hendrikse, N.H., Bart, J., van Waarde, A., Vaalburg, W. Mol. Imaging. Biol (2005)
- Evaluation of [18F]fluorinated sigma receptor ligands in the conscious monkey brain. Elsinga, P.H., Tsukada, H., Harada, N., Kakiuchi, T., Kawamura, K., Vaalburg, W., Kimura, Y., Kobayashi, T., Ishiwata, K. Synapse (2004)
- PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Elsinga, P.H., Hendrikse, N.H., Bart, J., Vaalburg, W., van Waarde, A. Curr. Pharm. Des. (2004)
- Receptor imaging in the thorax with PET. Elsinga, P.H., van Waarde, A., Vaalburg, W. Eur. J. Pharmacol. (2004)
- Radiopharmaceutical chemistry for positron emission tomography. Elsinga, P.H. Methods (2002)
- Imaging of beta-adrenoceptors in the human thorax using (S)-[(11)C]CGP12388 and positron emission tomography. Elsinga, P.H., Doze, P., van Waarde, A., Pieterman, R.M., Blanksma, P.K., Willemsen, A.T., Vaalburg, W. Eur. J. Pharmacol. (2001)
- Synthesis and evaluation of (S)-4-(3-(2'-[11C]isopropylamino)-2-hydroxypropoxy) -2H-benzimidazol -2-one ((S)-[11C]CGP 12388) and (S)-4-(3-((1'-[18F]-fluoroisopropyl)amino)-2-hydroxypropoxy) -2H- benzimidazol-2-one ((S)-[18F]fluoro-CGP 12388) for visualization of beta-adrenoceptors with positron emission tomography. Elsinga, P.H., van Waarde, A., Jaeggi, K.A., Schreiber, G., Heldoorn, M., Vaalburg, W. J. Med. Chem. (1997)